| Mr Michael Beshay, CRNA | |
|
129 N Washington St, Sumter, SC 29150-4949 | |
| (803) 774-9000 | |
| Not Available |
| Full Name | Mr Michael Beshay |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 129 N Washington St, Sumter, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477965564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 93559 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health | Columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Musc Community Physicians | 6507260668 | 698 |
News Archive
Infections contracted during surgical operations are a serious healthcare problem, leading to death in some cases. Now, a research project at the University of Huddersfield is investigating the use of nanoparticles as a way to disinfect wounds. It could prove to be much more effective than existing techniques because the particles would be tiny enough to enter the skin via hair follicles, ensuring much better penetration of the area affected by surgery.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine storm. Ponatinib is an oral drug used for the treatment of chronic myeloid leukemia (CML).
Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.
A report in the 2008 Jan issue of Psychotherapy and Psychosomatics by a group of Dutch investigators explores the relationship between alexithymia (the inability to express emotions) and the tolerance of negative emotions.
› Verified 3 days ago
| Entity Name | Medical University Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255305876 PECOS PAC ID: 1557268950 Enrollment ID: O20031215000499 |
News Archive
Infections contracted during surgical operations are a serious healthcare problem, leading to death in some cases. Now, a research project at the University of Huddersfield is investigating the use of nanoparticles as a way to disinfect wounds. It could prove to be much more effective than existing techniques because the particles would be tiny enough to enter the skin via hair follicles, ensuring much better penetration of the area affected by surgery.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine storm. Ponatinib is an oral drug used for the treatment of chronic myeloid leukemia (CML).
Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.
A report in the 2008 Jan issue of Psychotherapy and Psychosomatics by a group of Dutch investigators explores the relationship between alexithymia (the inability to express emotions) and the tolerance of negative emotions.
› Verified 3 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
Infections contracted during surgical operations are a serious healthcare problem, leading to death in some cases. Now, a research project at the University of Huddersfield is investigating the use of nanoparticles as a way to disinfect wounds. It could prove to be much more effective than existing techniques because the particles would be tiny enough to enter the skin via hair follicles, ensuring much better penetration of the area affected by surgery.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine storm. Ponatinib is an oral drug used for the treatment of chronic myeloid leukemia (CML).
Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.
A report in the 2008 Jan issue of Psychotherapy and Psychosomatics by a group of Dutch investigators explores the relationship between alexithymia (the inability to express emotions) and the tolerance of negative emotions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Beshay, CRNA 661 Promenade Pl, Apt #415, Columbia, SC 29229-6915 Ph: (864) 363-1194 | Mr Michael Beshay, CRNA 129 N Washington St, Sumter, SC 29150-4949 Ph: (803) 774-9000 |
News Archive
Infections contracted during surgical operations are a serious healthcare problem, leading to death in some cases. Now, a research project at the University of Huddersfield is investigating the use of nanoparticles as a way to disinfect wounds. It could prove to be much more effective than existing techniques because the particles would be tiny enough to enter the skin via hair follicles, ensuring much better penetration of the area affected by surgery.
Researchers at the Human Biology Division, Fred Hutchinson Cancer Research Center in Washington, United States, found that the FDA-approved, multi-kinase inhibitor Ponatinib is a potent inhibitor of the N-terminal domain (NTD) -mediated cytokine storm. Ponatinib is an oral drug used for the treatment of chronic myeloid leukemia (CML).
Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today that it has received its first order for a Renaissance system from Cordamed Biomedical Engineering Inc., its distribution partner in Turkey. This represents the first Renaissance system order in Turkey, and Cordamed will install the system at a prominent hospital in Istanbul.
Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.
A report in the 2008 Jan issue of Psychotherapy and Psychosomatics by a group of Dutch investigators explores the relationship between alexithymia (the inability to express emotions) and the tolerance of negative emotions.
› Verified 3 days ago
Mr. Johnny Raymon Chappell, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-778-9500 | |
Pamela L Thompson-knight, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-8775 | |
Roberto Lagarde, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-5203 | |
Sherri J Babb, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-5203 | |
Etna C Griffin, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-5203 | |
Shirley J Houser-stehr, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-5203 | |
Zachary T Kelly, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-9000 |